POCI
Precision Optics Corporation, Inc.NASDAQHealthcare$3.96+1.54%ClosedMarket Cap: $30.6M
As of 2026-04-09
Valuation
P/E (TTM)
—
PEG
—
P/B
3.27
P/S
1.25
EV/EBITDA
-5.27
DCF Value
$-19.26
FCF Yield
-10.4%
Div Yield
0.0%
Margins & Returns
Gross Margin
9.7%
Operating Margin
-27.6%
Net Margin
-28.3%
ROE
-60.6%
ROA
-30.2%
ROIC
-49.0%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q2 2026 | $7.4M | 2.8% | $-1.7M | $-1.8M | $-0.23 | — |
| Q1 2026 | $6.7M | 14.2% | $-1.6M | $-1.6M | $-0.21 | — |
| Q4 2025 | $6.2M | 12.9% | $-1.4M | $-1.4M | $-0.19 | — |
| FY 2025 | $19.1M | 17.8% | $-5.6M | $-5.8M | $-0.85 | — |
| Q3 2025 | $4.2M | 10.0% | $-2.0M | $-2.1M | $-0.30 | — |
| Q2 2025 | $4.5M | 23.6% | $-910.0K | $-969.7K | $-0.15 | — |
| Q1 2025 | $4.2M | 26.6% | $-1.2M | $-1.3M | $-0.21 | — |
| Q4 2024 | $4.7M | 21.7% | $-1.4M | $-1.4M | $-0.23 | — |
| FY 2024 | $19.1M | 30.3% | $-2.7M | $-3.0M | $-0.49 | — |
| Q3 2024 | $5.2M | 35.5% | $-258.5K | $-317.1K | $-0.05 | — |
| Q2 2024 | $4.8M | 30.1% | $-704.2K | $-758.8K | $-0.13 | — |
| Q1 2024 | $4.3M | 33.9% | $-405.3K | $-464.4K | $-0.08 | — |